116 related articles for article (PubMed ID: 32882767)
1. Use of Darunavir-Cobicistat as a Treatment Option for Critically Ill Patients with SARS-CoV-2 Infection.
Kim EJ; Choi SH; Park JS; Kwon YS; Lee J; Kim Y; Lee SY; Choi EY
Yonsei Med J; 2020 Sep; 61(9):826-830. PubMed ID: 32882767
[TBL] [Abstract][Full Text] [Related]
2. Lack of antiviral activity of darunavir against SARS-CoV-2.
De Meyer S; Bojkova D; Cinatl J; Van Damme E; Buyck C; Van Loock M; Woodfall B; Ciesek S
Int J Infect Dis; 2020 Aug; 97():7-10. PubMed ID: 32479865
[TBL] [Abstract][Full Text] [Related]
3. Simplification of ART in a patient living with multidrug resistant HIV-1: A case report using twice daily cobicistat and darunavir.
Brizzi MB; Novak RM; Chiampas TD
Int J STD AIDS; 2019 Nov; 30(13):1333-1336. PubMed ID: 31631777
[No Abstract] [Full Text] [Related]
4. Darunavir/Cobicistat Is Associated with Negative Outcomes in HIV-Negative Patients with Severe COVID-19 Pneumonia.
Milic J; Novella A; Meschiari M; Menozzi M; Santoro A; Bedini A; Cuomo G; Franceschini E; Digaetano M; Carli F; Ciusa G; Volpi S; Bacca E; Franceschi G; Yaacoub D; Rogati C; Tutone M; Burastero G; Faltoni M; Iadisernia V; Dolci G; Cossarizza A; Mussini C; Pasina L; Guaraldi G
AIDS Res Hum Retroviruses; 2021 Apr; 37(4):283-291. PubMed ID: 33619997
[TBL] [Abstract][Full Text] [Related]
5. Coronavirus disease-2019 in cancer patients. A report of the first 25 cancer patients in a western country (Italy).
Stroppa EM; Toscani I; Citterio C; Anselmi E; Zaffignani E; Codeluppi M; Cavanna L
Future Oncol; 2020 Jul; 16(20):1425-1432. PubMed ID: 32403946
[No Abstract] [Full Text] [Related]
6. Comparative Population Pharmacokinetics of Darunavir in SARS-CoV-2 Patients vs. HIV Patients: The Role of Interleukin-6.
Cojutti PG; Londero A; Della Siega P; Givone F; Fabris M; Biasizzo J; Tascini C; Pea F
Clin Pharmacokinet; 2020 Oct; 59(10):1251-1260. PubMed ID: 32856282
[TBL] [Abstract][Full Text] [Related]
7. Clinical Features and Outcomes of 98 Patients Hospitalized with SARS-CoV-2 Infection in Daegu, South Korea: A Brief Descriptive Study.
Hong KS; Lee KH; Chung JH; Shin KC; Choi EY; Jin HJ; Jang JG; Lee W; Ahn JH
Yonsei Med J; 2020 May; 61(5):431-437. PubMed ID: 32390367
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of Streptococcus Pneumoniae Urinary Antigen Testing in Decreasing Mortality of COVID-19 Co-Infected Patients: A Clinical Investigation.
Desai A; Santonocito OG; Caltagirone G; Kogan M; Ghetti F; Donadoni I; Porro F; Savevski V; Poretti D; Ciccarelli M; Martinelli Boneschi F; Voza A
Medicina (Kaunas); 2020 Oct; 56(11):. PubMed ID: 33138045
[TBL] [Abstract][Full Text] [Related]
9. Benign COVID-19 in an immunocompromised cancer patient - the case of a married couple.
Spezzani V; Piunno A; Iselin HU
Swiss Med Wkly; 2020 Apr; 150():w20246. PubMed ID: 32277836
[TBL] [Abstract][Full Text] [Related]
10. The Clinical Characteristics and Outcomes of Patients with Moderate-to-Severe Coronavirus Disease 2019 Infection and Diabetes in Daegu, South Korea.
Kim MK; Jeon JH; Kim SW; Moon JS; Cho NH; Han E; You JH; Lee JY; Hyun M; Park JS; Kwon YS; Choi YK; Kwon KT; Lee SY; Jeon EJ; Kim JW; Hong HL; Kwon HH; Jung CY; Lee YY; Ha E; Chung SM; Hur J; Ahn JH; Kim NY; Kim SW; Chang HH; Lee YH; Lee J; Park KG; Kim HA; Lee JH
Diabetes Metab J; 2020 Aug; 44(4):602-613. PubMed ID: 32794386
[TBL] [Abstract][Full Text] [Related]
11. Rezolsta® (Darunavir/Cobicistat): First Boosted Protease Inhibitor Co-formulated with Cobicistat.
Curran A; Pérez-Valero I; Moltó J
AIDS Rev; 2015; 17(2):114-20. PubMed ID: 26035169
[TBL] [Abstract][Full Text] [Related]
12. A special symptom of olfactory dysfunction in coronavirus disease 2019: report of three cases.
Chen C; Chen M; Cheng C; Chi Y; Hu Z; Liu Y; Huang S; Lv Y; Liang C; Jiao D; Yi Y; Zhang X; Sun W; Wei H
J Neurovirol; 2020 Jun; 26(3):456-458. PubMed ID: 32424616
[TBL] [Abstract][Full Text] [Related]
13. COVID-19 in people living with human immunodeficiency virus: a case series of 33 patients.
Härter G; Spinner CD; Roider J; Bickel M; Krznaric I; Grunwald S; Schabaz F; Gillor D; Postel N; Mueller MC; Müller M; Römer K; Schewe K; Hoffmann C
Infection; 2020 Oct; 48(5):681-686. PubMed ID: 32394344
[TBL] [Abstract][Full Text] [Related]
14. Microthrombi and ST-Segment-Elevation Myocardial Infarction in COVID-19.
Guagliumi G; Sonzogni A; Pescetelli I; Pellegrini D; Finn AV
Circulation; 2020 Aug; 142(8):804-809. PubMed ID: 32677840
[TBL] [Abstract][Full Text] [Related]
15. Darunavir concentrations in CSF of HIV-infected individuals when boosted with cobicistat versus ritonavir.
Bartels H; Decosterd L; Battegay M; Marzolini C
J Antimicrob Chemother; 2017 Sep; 72(9):2574-2577. PubMed ID: 28575323
[TBL] [Abstract][Full Text] [Related]
16. Analysis of type I IFN response and T cell activation in severe COVID-19/HIV-1 coinfection: A case report.
d'Ettorre G; Recchia G; Ridolfi M; Siccardi G; Pinacchio C; Innocenti GP; Santinelli L; Frasca F; Bitossi C; Ceccarelli G; Borrazzo C; Antonelli G; Scagnolari C; Mastroianni CM
Medicine (Baltimore); 2020 Sep; 99(36):e21803. PubMed ID: 32899009
[TBL] [Abstract][Full Text] [Related]
17. Darunavir/cobicistat once daily for the treatment of HIV.
Kakuda TN; Crauwels H; Opsomer M; Tomaka F; van de Casteele T; Vanveggel S; Iterbeke K; de Smedt G
Expert Rev Anti Infect Ther; 2015 Jun; 13(6):691-704. PubMed ID: 25962100
[TBL] [Abstract][Full Text] [Related]
18. Empiric Therapeutic Anticoagulation and Mortality in Critically Ill Patients With Respiratory Failure From SARS-CoV-2: A Retrospective Cohort Study.
Ferguson J; Volk S; Vondracek T; Flanigan J; Chernaik A
J Clin Pharmacol; 2020 Nov; 60(11):1411-1415. PubMed ID: 32885463
[TBL] [Abstract][Full Text] [Related]
19. Tocilizumab and steroid treatment in patients with COVID-19 pneumonia.
Mikulska M; Nicolini LA; Signori A; Di Biagio A; Sepulcri C; Russo C; Dettori S; Berruti M; Sormani MP; Giacobbe DR; Vena A; De Maria A; Dentone C; Taramasso L; Mirabella M; Magnasco L; Mora S; Delfino E; Toscanini F; Balletto E; Alessandrini AI; Baldi F; Briano F; Camera M; Dodi F; Ferrazin A; Labate L; Mazzarello G; Pincino R; Portunato F; Tutino S; Barisione E; Bruzzone B; Orsi A; Schenone E; Rosseti N; Sasso E; Da Rin G; Pelosi P; Beltramini S; Giacomini M; Icardi G; Gratarola A; Bassetti M
PLoS One; 2020; 15(8):e0237831. PubMed ID: 32817707
[TBL] [Abstract][Full Text] [Related]
20. Patient-Reported Outcomes in an Observational Cohort of HIV-1-Infected Adults on Darunavir/Cobicistat-Based Regimens: Beyond Viral Suppression.
Antinori A; Cossu MV; Menzaghi B; Sterrantino G; Squillace N; Di Cristo V; Cattelan A; Focà E; Castagna A; Orofino G; Valenti D; D'Ettore G; Aprea L; Ferrara S; Locatelli ME; Madeddu G; Pontali E; Scerbo P; Rossetti B; Uglietti A; Termini R; Rucci F; Gori A; Mancusi D
Patient; 2020 Jun; 13(3):375-387. PubMed ID: 32266663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
